Hers vs Hims: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Hims beats Hers overall, scoring 7.9/10 vs 7.3/10. Hims is more affordable at $175/mo vs $348/mo. Choose Hers for women who want glp-1 access from a well-known, publicly trad. Choose Hims for men who want glp-1 access from a well-known, publicly traded.
A side-by-side comparison of Hers and Hims covering pricing, scores, medication types, insurance, and more to help you decide.
Hers
#33 of 40The women's health arm of Hims & Hers Health (NYSE: HIMS), offering compounded GLP-1 medications with a polished app experience designed for women's health needs.
Visit HersHims
#12 of 40One of the largest and most recognized men's telehealth platforms in the US, offering compounded GLP-1 medications with a polished app experience and strong brand trust.
Visit Hims| Feature | Hers | Hims |
|---|---|---|
| Our Score | 7.3/10 | 7.9/10 |
| Starting Price | $348/mo | $175/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Women who want GLP-1 access from a well-known, publicly traded telehealth brand | Men who want GLP-1 access from a well-known, publicly traded telehealth brand |
| Ranking | #33 | #12 |
Pros & Cons Compared
Hers
Pros
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Women-focused branding, content, and support — not a men's health platform with a women's tab
- +$199/mo all-inclusive for compounded semaglutide with consultations and free shipping
- +Broader women's health platform — can address hormonal, skin, and wellness needs alongside weight loss
Cons
- −Pivoted away from some compounded formulations after FDA crackdown — medication availability can shift
- −Compounded only — no brand-name Wegovy or Zepbound through the platform
- −Generic support experience — large patient volume means less personalized attention
- −Higher price than competitors like TrimRx ($179) or Enhance MD ($115) for a similar compounded product
Hims
Pros
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Polished app and web experience — one of the best user interfaces in men's telehealth
- +$199/mo all-inclusive for compounded semaglutide with consultations and free shipping
- +Massive brand recognition and extensive customer support infrastructure
Cons
- −Pivoted away from some compounded formulations after FDA crackdown — medication availability can shift
- −Compounded only — no brand-name Wegovy or Zepbound through the platform
- −Generic support experience — large patient volume means less personalized attention
- −Higher price than competitors like TrimRx ($179) or Enhance MD ($115) for a similar compounded product
Our Verdict
Hims edges out Hers with a score of 7.9/10 vs 7.3/10. If budget is your priority, Hims starts at $175/mo compared to Hers's $348/mo. Choose Hers if you want: women who want glp-1 access from a well-known, publicly traded telehealth brand. Choose Hims if you want: men who want glp-1 access from a well-known, publicly traded telehealth brand.